Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2011.

  • Total revenue for the quarter ended December 31, 2011 was $164.9 million, which included net product sales of $160.9 million.
  • Non-GAAP operating income for the quarter ended December 31, 2011 was $17.6 million, compared to a non-GAAP operating income of $22.9 million for the same period in 2010.
  • Full year non-GAAP operating income was $25.7 million, compared to a non-GAAP operating loss of $4.4 million in 2010.
  • Cash, cash equivalents, short-term investments and restricted cash totaled $214.6 million at the end of the quarter.

  • "Our strong execution in 2011 has positioned us to enter 2012 with an extraordinary opportunity to maximize shareholder value. We generated positive operating cash flow, reacquired the full rights to the exenatide franchise, expanded the approved uses for BYETTA, and, most importantly, positioned ourselves well to successfully launch BYDUREON in the U.S. following its recent approval," said Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals. "We will also work to secure a new partner for exenatide outside the U.S. to advance our commitment to diabetes patients around the world, and continue to invest strategically in value-driving opportunities while continuing our focus on financial discipline."

    Highlights of Amylin's Fourth Quarter and Recent Activities

  • Received U.S. Food and Drug Administration (FDA) approval for BYDUREON™ (exenatide extended-release for injectable suspension) – the first and only once-weekly medication approved in the U.S. and the European Union for the treatment of type 2 diabetes. BYDUREON will be available in pharmacies throughout the U.S. later this month.

  • '/>"/>
    SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
    2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
    3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
    4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
    5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
    6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
    7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
    8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
    9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
    10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
    11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)... 2015  PD-Rx Pharmaceuticals, Inc., a publicly held ... partnered with Dobson Technologies, a fully-integrated outsourced IT ... product. PD-Rx is an Application Service ... States.  Using Dobson Technologies, IaaS solution will allow ... ensure regulatory compliance, and reduce operating expenses.  "The ...
    (Date:7/28/2015)... July 28, 2015   Vincari , known for ... has just hired John O,Neil as their ... has over 30 years of diverse and progressive experience ... executive healthcare experience coupled with Vincari,s CMO, Dr. ... Vincari to address the challenges both hospitals and surgeons ...
    (Date:7/28/2015)... July 28, 2015  Leaf Healthcare releases white ... ulcers place on the healthcare system . ... to modern quality healthcare. Research by the U.S. ... Healthcare Research and Quality shows that pressure ulcers ... billion a year. The condition is both excruciatingly ...
    Breaking Medicine Technology:PD-Rx Partners With Dobson Technologies 2John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3
    ... patients can drive safely six weeks following surgical,treatment, ... most patients, pain levels are so low that they ... car again. A study published in the August,2008 issue ... http://www.jbjs.org/ ),also found that emergency brake time response in ...
    ... Calif., Aug. 26 XTENT, Inc.,(Nasdaq: XTNT ) ... CUSTOM II trial was published in the most recent ... the article was,Dr. Pieter R. Stella, M.D., of University ... CUSTOM II Investigators from 13 clinical,sites across Europe., ...
    Cached Medicine Technology:Braking After Bunion Surgery 2Braking After Bunion Surgery 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4
    (Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was ... the nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The ... condition. , The CoreValve® Evolut® R System was approved by the U.S. Food and ...
    (Date:7/28/2015)... Costa Mesa, Calif (PRWEB) , ... July 28, ... ... disability in the United States with 1 in 68 children currently affected with ... to get their child on the road to recovery is extremely daunting. That’s ...
    (Date:7/28/2015)... ... July 28, 2015 , ... DuPont ... visit to Ethiopia to learn more about the impact of U.S. collaborations with ... initiative focuses on accelerating agricultural development as an engine of broad-based economic growth ...
    (Date:7/28/2015)... ... 2015 (PRWEB) July 28, 2015 , ... Nations Insurance Solutions, ... quotes to its clients, recently announced the launch of Commercial, Auto and Motorcycle ... specific needs. , Liability automobile insurance policies are one popular type of ...
    (Date:7/28/2015)... ... ... Women in Technology (WIT), the premier organization contributing to the success of professional ... Dezzutti, CEO and president at Market Connections, Inc. as the organization’s president of the ... empowers women to thrive and excel in the technology field. In order to do ...
    Breaking Medicine News(10 mins):Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2
    ... , TAMPA, Fla., Sept. 1 Amazing medical advancements ... they,ve ever been before. As a result, people are living longer ... an aging population and new medical discoveries has created a huge ... any level -- from one-year Licensed Practical Nurse (LPN) ...
    ... Preliminary findings in ferrets suggest that the novel 2009 ... researchers say. Tests in animals showed that levels ... levels of the seasonal virus strains, and the new ... findings by other research groups, the University of Maryland ...
    ... of their physicians, disclosure may be key to gaining ... Bloomberg School of Public Health. However, a positive perception ... risk a physician faces. Researchers examined volunteer responses to ... along with variations in the extent to which a ...
    ... Gene therapy holds promise in the treatment of a ... among many others. However, developing a scalable system for ... been challenging. Now a team of Northwestern University ... novel gene delivery technology that combines key properties in ...
    ... , , Third annual PCPCC Summit ... the patient centered medical home , , WASHINGTON, ... aisle hotly debate how to extend health care coverage to more Americans ... converge on Washington, DC to make their case for a fundamentally improved ...
    ... , , , , ... lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, ... (CHD) even in patients who achieve or surpass current low density ... the Multimedia News Release, go to: http://www.prnewswire.com/mnr/r3i/39757/ ...
    Cached Medicine News:Health News:Saving Lives Is a Growth Industry 2Health News:Saving Lives Is a Growth Industry 3Health News:Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza 2Health News:Patient perception is vital when reporting medical errors 2Health News:Promise of nanodiamonds for safer gene therapy 2Health News:Promise of nanodiamonds for safer gene therapy 3Health News:All Eyes on The Medical Home: Patient-Centered Primary Care Collaborative Convenes National Summit In Washington, DC 2Health News:All Eyes on The Medical Home: Patient-Centered Primary Care Collaborative Convenes National Summit In Washington, DC 3Health News:Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 2Health News:Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 3Health News:Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 4Health News:Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 5Health News:Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 6Health News:Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 7Health News:Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol 8
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: